Found 69 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years - 60 years
Accepts healthy volunteer
All genders
Phase 1
This study investigates the pharmacokinetic characteristics of a single subcutaneous dose of an investigational medication in healthy participants. The purpose of this study is to evaluate the investigational medication coformulated with another substance and without it.The study focuses on understanding how the investigational medication behaves in the body and its …
Accepts healthy volunteer
All genders
Observational
This study investigates the effects of an investigational vaccine on pregnancy outcomes. The study focuses on exposure to the vaccine during pregnancy.The study evaluates various outcomes related to maternal health, obstetrical events, and infant development. It focuses on understanding the effects of the investigational vaccine on both mothers and their …
18 years or above
All genders
Observational
This study investigates chronic inflammatory demyelinating polyneuropathy (CIDP).The study evaluates treatment outcomes for individuals with CIDP who have been on standard care for at least three months.Who can participate: Adults aged 18 and older with a neurologist-confirmed diagnosis of CIDP who have been using specific CIDP treatments for three months …
1 year or above
All genders
Observational
This study investigates eosinophilic esophagitis. It focuses on patients who have recently been prescribed an investigational medication as part of their standard care.The study evaluates the use of this investigational medication in routine treatment settings. It looks at various aspects like patient experiences, symptoms, and quality of life changes.Who can …
18 years or above
All genders
Phase 1/2
Interventional
The purpose of this study is to investigate an investigational medication when combined with novel agents in individuals with relapsed or refractory myeloma. This study includes different substudies, some of which are controlled, while others are independent.This study evaluates how well the investigational medication works when used with other treatments. …
18 years - 90 years
All genders
Phase 3
Interventional
The purpose of this study is to investigate the effects of an investigational medication on chronic pruritus of unknown origin (CPUO).This study evaluates the safety and effectiveness of the investigational medication. It seeks to understand how well the medication works and how safe it is for people with CPUO.Who can …
18 years or above
All genders
Phase 1/2
Interventional
This study investigates advanced solid tumors. Participants will receive an investigational medication alone or with other treatments.The purpose of this study is to evaluate the safety and initial effectiveness of the investigational medication in adults with advanced solid tumors.Who can participate: Adults aged 18 and older with advanced solid tumors …
2 years - 5 years
All genders
Phase 3
Interventional
This study investigates asthma and asthmatic wheeze in children aged 2 to under 6 years. The purpose of this study is to evaluate the effects of an investigational medication on these conditions.The study focuses on understanding the safety and effectiveness of the investigational medication over a long period. Researchers will …
12 years or above
All genders
Phase 3
Interventional
This study investigates moderate-to-severe AD in participants aged 12 years and older. It focuses on those who have had an inadequate response to prior biologic therapy or an oral JAK inhibitor.The purpose of this study is to evaluate the effectiveness and safety of an investigational medication given by subcutaneous injection. …
16 years - 75 years
All genders
Phase 2
Interventional
This study investigates primary focal segmental glomerulosclerosis (FSGS) and primary minimal change disease (MCD).The purpose of this study is to evaluate the effectiveness and safety of investigational medications in managing proteinuria and its effects on nephrotic syndrome remission rates.Who can participate: Participants aged 16 to 75 years with a biopsy …